Antonio Sánchez-Cordero

Healthcare Private Equity Investor, Principal at ARCHIMED

Greater Boston

About

Global healthcare private equity investor at Archimed. I am singularly committed to the identification and cultivation of strategic investment opportunities within the realms of medical devices and diagnostics. My approach is predicated on forging robust partnerships with enterprises at the forefront of innovation, where our shared endeavour is to propel growth, enhance profitability, and effectuate a significant, positive impact on patient outcomes. Previously, I have been an executive with more than 15 years of experience in the healthcare industry, leading mid-to-large size multinationals in the areas of corporate and business development, strategy and M&A. Experienced at leveraging inorganic growth to build sustainable businesses while further developing the organizational capabilities and the innovation pipeline of the organization.

Experience

  • Principal at ARCHIMED
    Mar 2024 - Present · 2 yrs 4 mos

  • Group Vice President, Strategy & Business Development (M&A), Specialty Diagnostics at Thermo Fisher Scientific
    Sep 2022 - Feb 2024 · 1 yr 6 mos

  • Worldwide Vice President, Business Development (M&A) & Strategy at BD
    May 2021 - Sep 2022 · 1 yr 5 mos

  • Senior Vice President, Corporate Strategy, Business Development & Licensing at PDI
    Jan 2018 - May 2021 · 3 yrs 5 mos

  • Operating Partner at Ampersand Capital Partners
    Apr 2017 - Jan 2018 · 10 mos